NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Ansys (ANSS) upgraded at Baird from Market Perform to Outperform, Robert Baird said. $76 price target. Company is a clear market leader and can continue to gain market share.
Becton Dickinson (BDX) downgraded at Leerink to Market Perform, Leerink Swann said. Valuation call, based on an $80 price target.Cigna (CI - Get Report) upgraded at BMO from Market Perform to Outperform, BMO Capital said. $55 price target. Earnings power should improve in the coming quarters. Concur (CNQR) downgraded at Goldman from Neutral to Sell, Goldman Sachs said. Valuation call, as the stock is up 51% over the past year. $56 price target. Jack in the Box (JACK) downgraded at Lazard from Buy to Neutral, Lazard said. Valuation call, as the stock is up 25% year-to-date. Nordstrom (JWN) downgraded at Baird from Outperform to Neutral, Robert Baird said. Valuation call, based on a $59 price target. Molycorp (MCP) downgraded at JPMorgan from Neutral to Underweight, JP Morgan said. $11.50 price target. Company is facing a potential funding shortfall. MercadoLibre (MELI) upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. $100 price target. Company is leveraged to increased e-commerce adoption across Latin America. Annaly Capital (NLY) downgraded at Wunderlich from Buy to Hold, Wunderlich said. $18 price target. Company could see higher prepayments in the near term. OpenTable (OPEN) upgraded at Oppenheimer to Outperform from Perform, Oppenheimer said. $46 price target. Greater chance of positive catalysts. Palo Alto (PANW) rated new Outperform at William Blair. Company can gain market share in the firewall upgrade cycle. Ralcorp Holdings (RAH) upgraded at UBS to Buy from Neutral, UBS said. $75 price target. Pullback and better FY13 means stock upside. Sempra Energy (SE) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $30 price target. Estimates also slashed, given commodity exposure. Steris (STE - Get Report) upgraded at JMP from Market Perform to Outperform, JMP Securities said. $38 price target. Company appears to be at the beginning of a multi-year margin expansion story.